JD vs KLRS
JD.com Inc Adr (JD) versus Kalaris Therapeutics, Inc. (KLRS) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Kalaris Therapeutics, Inc. (KLRS) is a biotechnology company listed on US.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
KLRS does not have a complete income-statement cache yet.
JD currently screens at market cap $45.56B and trailing P/E 7.6. KLRS currently screens at market cap $0.
Not investment advice. Open the JD and KLRS stock pages for the full models.
Not investment advice.